First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center Join the University of Vermont Cancer Center as Participating Clinical Sites The PanTheR Study is Gathering Expanded Safety and Performance Data of the FDA-Cleared RenovoCath® Device and its Associated Survival Outcomes in Patients Diagnosed with Solid Tumors MOUNTAIN VIEW, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ( ...